PFS
PASG icon

Prospera Financial Services’s Passage Bio PASG Stock Holding History

Prospera Financial Services’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-5
Closed – – 2302
2022
Q1 		$0 Buy
+5
New +$412 ﹤0.01% 2768

Other funds holding PASG

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HCM
Highline Capital Management New York $53.5M AUM 21.72% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Prospera Financial Services's PASG Position: Q2 2022 in Review

Prospera Financial Services sold out of Passage Bio (PASG) in Q2 2022, closing a stake of 5 shares.

Prospera Financial Services first reported a position in PASG in Q1 2022 and held it in 1 quarter. The position peaked at $0 in Q1 2022. 85 funds tracked by Wall St. Rank hold PASG as of Q2 2022.

  • Prospera Financial Services reported no remaining Passage Bio position as of Q2 2022 after selling out during the quarter.
  • Prospera Financial Services sold 5 Passage Bio shares in Q2 2022.
  • Prospera Financial Services first reported a position in Passage Bio in Q1 2022 and held it in 1 quarter.
  • Prospera Financial Services's Passage Bio position peaked at $0 in Q1 2022.
  • 85 funds tracked by Wall St. Rank held Passage Bio as of Q2 2022.

Based on Prospera Financial Services's 13F filing for Q2 2022, filed 8 Aug 2022.